Agfa names new Impax sales teamAgfa continues to solidify the integration of Sterling Diagnostic Imaging assets into its PACS and conventional imaging businesses (PNN 8/99). Most recently, the PACS and film giant revamped its sales
Agfa continues to solidify the integration of Sterling Diagnostic Imaging assets into its PACS and conventional imaging businesses (
PNN
8/99). Most recently, the PACS and film giant revamped its sales organization, separating the Impax digital image management and computed radiography business functions from its conventional imaging and hard-copy systems sales. Agfa also announced several key appointments to its sales teams.
John Scarano will now head up the Impax North American sales force. Those reporting to Scarano include John DeSantis, who previously directed Agfas military radiology sales and will now be responsible for Impax sales to the government; Andrea Harding, who had been responsible for western region PACS sales at Sterling and will now manage commercial Impax sales in the central and western regions; and Anthony Passarello, who was Agfas director of southeastern regional sales and will now lead Impax sales for the commercial market in the northeast and southern regions.
In the new Imaging Systems group, Bruce Gower will handle sales in the corporate healthcare sector. He was previously with Sterling as zone general manager.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.